Healthy Skepticism Library item: 19358
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
OTC Review & Outlook 2011
Pharma Live 2011
http://www.pharmalive.com/special_reports/details.cfm?reportID=336
Full text:
OTC Review and Outlook 2011
Introductory rate of $345 expires 3/31/11. Save $70 off the regular rate of $415. Click the sample link below to view the complete table of contents and select pages.
The global market for consumer-care products generated slower growth in 2010 than during the previous year, partially because of a weaker flu season in North America and Europe. However, emerging markets for OTC products continue to expand, lead by China. The markets in India and Latin America also remain on a solid growth pattern.
Driving forces in the U.S. over-the-counter market include Rx-to-OTC switches of former blockbuster brands as well as consumers’ increasing usage of self medication. More than 300,000 OTC products are on the U.S. market, and the Food and Drug Administration has separated them into 80-plus classes based on their intended therapeutic uses. Leading therapeutic categories/medical-usage areas for OTC products include cholesterol therapy; contraception; cough, cold and allergy; dermatology; gastrointestinal disorders; pain management; sexual dysfunction; and weight management/obesity.
OTC data featured in this special report include:
• Company Profiles
• FDA OTC Approvals on the market
• Ingredients and Dosages Transferred from RX-to-OTC Status
• OTC Product U.S. Patent Data
• OTC Devices by Class
